A Morphological Study on the Effect of Cyproterone Acetate on Human Prostatic Carcinoma

REFERENCES

• Bard, D. R. & Lasnitzki, I. 1977. The influence of oestradiol on the metabolism of androgens by human prostatic tissue. J Endocr 74, 1.
   PubMed Web of Science ®Google Scholar
• Baulieu, E.-E. & Jung, I. 1970. A prostatic cytosol receptor. Biochem Biophys Res Comm 38, 599.
   PubMed Web of Science ®Google Scholar
• Brotherton, J. 1974. Effect of oral Cyproterone acetate on urinary and serum FSH and LH levels in adult males being treated for hypersexuality. J Reprod Fert 36, 177.
   PubMedGoogle Scholar
• Brotherton, J. & Barnard, G. 1974. Some aspects of the effect of Cyproterone acetate on levels of other steroid hormones in man. J Reprod Fert 36, 373.
   PubMedGoogle Scholar
• Bruchovsky, N. & Wilson, J. D. 1968. The conversion of testosterone to to 5α-androstan-17β-01-3-one by rat prostate in vivo and in vitro. J Biol Chem 243, 2012.
   PubMed Web of Science ®Google Scholar
• Dahl, E. & Tveter, K. J. 1974. The ultrastructure of the accessory sex organs of the male rat. V. Effect of the anti-androgenic compund Cyproterone acetate. J Endocr 62, 251.
   PubMed Web of Science ®Google Scholar
• Djoeseland, O., Tveter, K. J., Attramadal, A., Hansson, V., Haugen, H. N. & Mathisen, W. 1977. Metabolism of testosterone in the human prostate and seminal vesicles. Scand J Urol nephrol 11, 1.
   PubMedGoogle Scholar
• Fang, S., Anderson, K. M. & Liao, S. 1969. Receptor protein for androgens. On the role of specific proteins in the retention of 17β-hydroxy-5α-androstan-3-one by the rat ventral prostate in vivo and in vitro. J Biol Chem 244, 6584.
   PubMed Web of Science ®Google Scholar
• Fang, S. & Liao, S. 1969. Antagonistic action of antiandrogens on the formation of a specific dihydro-testosterone-receptor protein complex in rat ventral prostate. Mol Pharmac 5, 420.
   PubMedGoogle Scholar
• Fang, S. & Liao, S. 1971. Androgen receptors. Steroid-and tissue-specific retention of a 17β-hydroxy-5α-an-drostan-3-one protein complex by the cell nuclei of ventral prostate. J Biol Chem 246, 16.
   PubMed Web of Science ®Google Scholar
• Geller, J., Vazakas, G., Fruchtman, B., Newman, H., Nakao, K. & Loh, A. 1968. The effect of Cyproterone acetate on advanced carcinoma of the prostate. Surg Gynecol Obstet 127, 748.
   PubMedGoogle Scholar
• Geller, J., Fishman, J. & Cantor, T. L. 1975. Effect of Cyproterone acetate on clinical, endocrine and pathological features of benign prostatic hypertrophy. J Steroid Biochem 6, 837.
   PubMedGoogle Scholar
• Gleason, D. F. 1977. Histological grading and clinical staging of prostatic carcinoma. In: Urologic pathology; The prostate. ed. M.Tannenbaum, Lea & Febiger, Philadelphia.
   Google Scholar
• Gleason, D. F. & Mellinger, G. T. 1974. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol 111, 58.
   PubMed Web of Science ®Google Scholar
• Grigorescu, A. & Villee, C. A. 1973. Antagonistic effects of dihydrotestosterone and Cyproterone acetate on the synthesis of RNA. Biochem Biophys Acta 319, 165.
   PubMedGoogle Scholar
• Habib, F. K., Lee, I. R., Stitch, S. R. & Smith, P. H. 1976. Androgen levels in the plasma and prostatic tissue of patients with benign hypertrophy and carcinoma of the prostate. J Endocr 71, 99.
   PubMed Web of Science ®Google Scholar
• Hohbach, C. 1977. Ultrastructural and histochemical studies of the prostate of dog under Cyproterone acetate. Invest Urol 15, 117.
   PubMedGoogle Scholar
• Jameson, K. M. 1976. Regression of penile metastases of prostatic carcinoma with Cyproterone acetate therapy. Br J Urol, 48 268.
   PubMedGoogle Scholar
• Loving, C. K. & Flickinger, C. J. 1976. Alterations in the fine structure of the prostate and seminal vesicle of rats treated with Cyproterone acetate. Anat Rec 185, 13.
   PubMedGoogle Scholar
• Mainwaring, W. I. P. 1969. A soluble androgen receptor in the cytoplasm of rat prostate. J Endocr 45, 531.
   PubMed Web of Science ®Google Scholar
• Mainwaring, W. I. P. 1977. The mechanism of action of androgens. Monographs on endocrinology. Springer-Verlag, Heidelberg.
   Google Scholar
• Mainwaring, W. I. P. & Peterken, B. M. 1971. A reconstituted, cell-free system for the specific transfer of steroidreceptor complexes into nuclear chromatin isolated from rat ventral prostate gland. Biochem J 125, 285.
   PubMed Web of Science ®Google Scholar
• Morfin, R. F., Leav, I., Charles, J.-F., Cavazos, L. F., Ofner, P. & Floch, H. H. 1977. Correlative study of the morphology and C19-steroid metabolism of benign and cancerous human prostatic tissue. Cancer 39, 1517.
   PubMed Web of Science ®Google Scholar
• Neumann, F., von Berswordt-Wallrabe, R., Elger, W. & Steinbeck, H. 1970. Aspects of androgen-dependent events as studied by anti-androgens. Recent Progr Horm Res 26, 337.
   PubMedGoogle Scholar
• Neumann, F. 1977. Pharmacology and potential use of Cyproterone acetate. Horm Metab Res 9, 1.
   PubMed Web of Science ®Google Scholar
• Prout, G. R., Jr, Kliman, B., Daly, J. J., Maclaughlin, R. A. & Griffin, P. P. 1976. In vitro uptake of 3H testosterone and its conversion to dihydrotestosterone by prostatic carcinoma and other tissue. J Urol 166, 603.
   Google Scholar
• Siiteri, P. K. & Wilson, J. D. 1970. Dihydrotestosterone in prostatic hypertrophy. J Clin Invest 49, 1737.
   PubMed Web of Science ®Google Scholar
• Smith, R. B., Walsh, P. C. & Goodwin, W. E. 1973. Cyproterone acetate in the treatment of advanced carcinoma of the prostate. J Urol 110, 106.
   PubMed Web of Science ®Google Scholar
• Tveter, K. J. & Aakvaag, A. 1969. Uptake and metabolism of testosterone-1, 2-3H by accessory sex organs of male rats; influence of some hormonal compounds. Endocrinology 85, 683.
   PubMed Web of Science ®Google Scholar
• Tveter, K. J., Attramadal, A., Aakvaag, A. & Hansson, V. 1971. Androgenic receptors in rat and human prostate. Adv Biosci 7, 193.
   Google Scholar
• Tveter, K. J., Dahl, E. & Kjaerheim, Å. 1975. Ultrastructural changes induced by Cyproterone acetate in the rat prostate. In: Normal and abnormal growth of the prostate, ed M.Goland, Charles C. Thomas, Springfield, Ill.
   Google Scholar
• Tveter, K. J., Otnes, B. & Hannestad, R. 1978. The treatment of prostatic carcinoma with Cyproterone acetate. Scand J Urol Nephrol 12, 115.
   PubMed Web of Science ®Google Scholar
• Unhjem, O., Tveter, K. J. & Aakvaag, A. 1969. Preliminary characterization of an androgen-macromolecular complex in rat ventral prostate. Acta Endocr 62, 153.
   PubMedGoogle Scholar
• Wein, A. J. & Murphy, J. J. 1973. Experience in the treatment of prostatic carcinoma with Cyproterone acetate. J Urol 109, 68.
   PubMed Web of Science ®Google Scholar